Open AccessMedicine
G. Kahaly, L. Bartalena, L. Hegedüs, L. Leenhardt, K. Poppe, S. Pearce
2018.7.25European Thyroid Journal
tlooto Summary
If a patient relapses after completing a course of ATD, definitive treatment is recommended; however, continued long-term low-dose MMI can be considered, and steroid prophylaxis is warranted in Graves’ patients with mild/active orbitopathy receiving RAI.
Abstract
Abstract is not available.
Citation format
KAHALY, G., et al. 2018 European thyroid association guideline for the management of graves’ hyperthyroidism. European Thyroid Journal, 2018, 7: 167–186.